Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study. (Q44904629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Robert James Hamilton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Daniel M. Moreira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

S J Freedland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Gerber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L L Banez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

G L Andriole

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

R S Rittmaster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

9 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

254-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2013.10

28 February 2020

exact match

0 references

cites work

Rationale for statins in the chemoprevention of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin drugs and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and risk of prostate cancer in the California Men's Health Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

The association between statin use and the diagnosis of prostate cancer in a population based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statins and prostate cancer diagnosis and grade in a veterans population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and risk of prostate cancer in a population of men who underwent biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

The influence of statin medications on prostate-specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Effect of dutasteride on the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and risk of prostate cancer: results from a population-based epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Cancer risk among statin users: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and the risk of 10 cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statins and risk of cancer: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Statin use and risk of prostate cancer recurrence in men treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Relationship of statins to clinical presentation and biochemical outcomes after radical prostatectomy in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

Do statins affect androgen levels in men? Results from the Boston area community health survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.10

31 March 2020

Identifiers

DOI

10.1038/PCAN.2013.10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23567655%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference